• LpqH Microvesicles for Macrophage-Targeted mRNA

  2026-09-01

  Huo et al. engineered LpqH-tagged extracellular vesicles to improve delivery of mRNA into macrophages, finding that tagged microvesicles combined stronger targeting with higher mRNA encapsulation than tagged exosomes and commercial lipid nanoparticles. Vaccine studies using VP1- or RBD-encoding mRNA further showed enhanced humoral and adaptive immune responses, supporting microvesicles as a tunable carrier platform while leaving important questions about manufacturing, biodistribution, and human translation.

• DED Assembly in FADD–Procaspase-8–cFLIP Signaling

  2026-09-01

  The reference study resolves how FADD, procaspase-8, and cFLIP assemble through death-effector domains to regulate apoptosis, survival, and necroptosis. By combining X-ray crystallography, cryo-electron microscopy, and structure-guided mutagenesis, it provides an atomic framework for understanding limited caspase-8 activation and RIPK1 control.

• Arachidonic Acid Promotes Vaccine Humoral Immunity

  2026-08-31

  The reference study shows that dietary arachidonic acid can strengthen and accelerate rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its central mechanistic contribution is linking lymph-node arachidonic acid metabolism, prostaglandin I2 signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.

• a-MSH, Amide: Mechanism and Research Workflows

  2026-08-31

  a-MSH, amide is a synthetic alpha-melanocyte-stimulating hormone amide used to study melanocortin signaling, melanin synthesis, and inflammatory pathways. Its strongest research value is as a defined receptor ligand and assay stimulus, not as evidence of clinical treatment efficacy.

• CK2 Phosphorylation Tunes LOH2 and Plant Immunity

  2026-08-30

  The reference study shows that casein kinase 2 regulates the Arabidopsis ceramide synthase LOH2 through phosphorylation at S289 and S291. This modification increases catalytic activity while also promoting polyubiquitination and proteasomal turnover, revealing a phosphorylation-dependent balance between sphingolipid production, cell death, and immune resistance.

• Protein A/G Magnetic Co-IP/IP Kit: Mechanistic Guide

  2026-08-29

  Discover how the Protein A/G Magnetic Co-IP/IP Kit supports rigorous protein-protein interaction analysis, using the RNF8–DAPK1 axis in ischemic-stroke research as a model for assay design, controls, and interpretation.

• Azilsartan Medoxomil Monopotassium Workflows

  2026-08-28

  Build reproducible AT1-receptor, cellular, and preclinical blood-pressure workflows with Azilsartan medoxomil monopotassium (TAK 491). The guide connects formulation control, sustained-binding experiments, and translational study design while separating assay recommendations from clinical evidence.

• Network Medicine Identifies Apigenin in Alzheimer’s

  2026-08-28

  A 2025 study used network medicine to screen flavonoids by their proximity to Alzheimer’s disease targets, prioritizing 48 candidates and identifying apigenin as the leading compound. Integrated network analysis and cell-based validation linked apigenin to mitochondrial protection, apoptosis suppression, AKT/NF-κB regulation, and microglial polarization, while also highlighting important limits for translation.

• Anlotinib hydrochloride in Angiogenesis Assays

  2026-08-27

  Anlotinib hydrochloride gives researchers a practical way to connect endothelial migration, tube formation, receptor phosphorylation, and tumor angiogenesis in one workflow. Its multi-target profile supports mechanism-driven cancer research while its low cytotoxicity at functional concentrations helps distinguish pathway inhibition from nonspecific cell loss.

• Lysis Buffer for Decision-Ready Mouse Genotyping

  2026-08-27

  Discover how lysis buffer chemistry supports genomic DNA release from mouse tail tissue and improves decision-ready mouse genotyping. This article connects pre-analytical DNA quality, assay controls, and translational model interpretation without confusing genotype confirmation with cancer biomarker profiling.

• ZIF8 Nanotheranostics for TNBC: Study Insights

  2026-08-26

  Li et al. developed FA-PEG@ZIF8@CIP, a folate-targeted, pH-responsive nanoplatform that combines ultrasound imaging with ciprofloxacin-based sonodynamic therapy, chemotherapy, and immune activation. The study links ultrasound-enhanced ROS production to immunogenic cell death, dendritic-cell maturation, and increased CD8+ T-cell infiltration, while identifying important control and translation requirements for future validation.

• Alternariol (AOH) for Reliable Cell Assays

  2026-08-26

  Alternariol (AOH), SKU C5061, provides a chemically defined research reagent for investigating cell viability, cytoskeletal effects, apoptosis, and mycotoxin-associated hepatic responses. This scenario-based guide explains stock preparation, assay controls, endpoint interpretation, and practical supplier-selection criteria for more defensible laboratory workflows.

• Birinapant (TL32711) and the Apoptosis Decision

  2026-08-25

  Birinapant (TL32711) offers a mechanistically focused way to interrogate IAP-dependent apoptosis resistance. When paired with the MDM1–p53 findings in colorectal cancer, it supports a biomarker-led framework for studying TNF and TRAIL signaling, caspase activation, and chemoradiotherapy sensitization—while keeping the distinction between established evidence and translational hypothesis explicit.

• Annexin V-Cy5/DAPI Apoptosis Kit for Ph+ ALL

  2026-08-25

  Translate PS exposure and membrane integrity into a rapid, two-parameter readout for TKI-treated leukemia cells. This apoptosis detection kit supports both flow cytometry and fluorescence microscopy, making it useful for connecting P2RX1-driven mitochondrial stress with functional cell-death outcomes.

• CDK9 inhibitor (A3294): Lab Workflow Guide

  2026-08-24

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for studying CDK9-dependent transcription elongation and HIV-1 propagation inhibition without treating the compound as a general cytotoxic agent. It is suitable for focused biochemical and cellular pathway experiments, but not for pan-CDK inhibition, broad cell-cycle regulation studies, or protocols that require long-term storage of prepared solutions.

7956 records 1/531 page Next 12345 下5页 Last page